首页 | 官方网站   微博 | 高级检索  
     

达芬奇机器人系统与胸腔镜在肺癌根治术中的近期疗效比较及经验探讨
引用本文:张真发,岳东升,王勐,赵晓亮,李晨光,高留伟,陈晨,王长利.达芬奇机器人系统与胸腔镜在肺癌根治术中的近期疗效比较及经验探讨[J].中国肿瘤临床,2021,48(10):511-515.
作者姓名:张真发  岳东升  王勐  赵晓亮  李晨光  高留伟  陈晨  王长利
作者单位:天津医科大学肿瘤医院肺部肿瘤科,国家肿瘤临床医学研究中心,天津市恶性肿瘤临床医学研究中心,天津市“肿瘤防治”重点实验室 (天津市 300060)
摘    要:  目的  对比分析达芬奇机器人与胸腔镜辅助非小细胞肺癌根治术的近期效果,同时结合本中心开展的经验,探讨达芬奇机器人使用过程中的心得体会。  方法  分析2016年8月至2020年9月于天津医科大学肿瘤医院行手术治疗的非小细胞肺癌患者的相关临床数据,分为达芬奇机器人组和胸腔镜辅助组,两组分别纳入467例,进行围手术期关键指标分析。  结果  与胸腔镜组相比,达芬奇机器人组在手术时间、术中失血量、淋巴结清扫站数、淋巴结清扫个数及淋巴结清扫N2站数、术后住院时间、术后第一天引流量等均有统计数差异(均P<0.05)。  结论  随着对达芬奇机器人系统及手术流程的熟练掌握及操作流程优化,达芬奇机器人手术在非小细胞肺癌患者中更加安全可行,且术中出血量少,清扫淋巴结更彻底,术后住院时间更短。目前,初步数据显示达芬奇机器人手术可以成为胸腔镜手术安全可靠的替代方案。 

关 键 词:达芬奇机器人手术    胸腔镜辅助手术    非小细胞肺癌    根治术    近期疗效
收稿时间:2020-12-15

A comparative study and application experience of short-term effect between da Vinci robot-assisted radical surgery and video-assisted thoracic surgery in radical resection of lung cancer
Affiliation:Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Thrapy, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Abstract:  Objective  To compare the short-term outcomes of da Vinci robot-assisted thoracic surgery (RATS) with those of video-assisted thoracic surgery (VATS) in patients with non-small cell lung cancer (NSCLC). Simultaneously, the experience with RATS at Tianjin Medical University Cancer Institute and Hospital and application experience of da Vinci robots were explored.  Methods  Clinical data were collected from patients with NSCLC who underwent radical surgery at Tianjin Medical University Cancer Institute and Hospital from August 2016 to September 2020. Patients were assigned into the RATS group and the VATS group. A total of 467 cases were included in the two groups for comparative analyses.  Results  There were significant differences in the operation time, volume of blood loss, total number of lymph nodes dissected, total number of lymph node stations dissected, number of lymph nodes dissected at N2 stations, postoperative hospital stay, and volume of drainage fluid collected on the first day between the RATS and VATS groups (all P<0.05).  Conclusions  Proficiency in the da Vinci robotic system and operation process optimization lead to safer and more feasible surgical procedures in patients with NSCLC. Furthermore, intraoperative blood loss is less, a greater number of lymph nodes are removed, and the postoperative hospital stay is shorter. The current preliminary data show that da Vinci RATS is a safe and reliable alternative to VATS.  
Keywords:
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号